The Edetate Calcium Disodium Injecti, cataloged under National Stock Number 6505-01-717-0047, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-717-0047 |
| Primary Part Number | NDC64980-0588-51 |
| Item Name | Edetate Calcium Disodium Injecti |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR AND INTRAVENOUS |
| Primary Container Content Quantity | 5.0 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Total Primary Container Quantity | 5 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC64980-0588-51 PRIMARY | Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM239510 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1660466 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-717-0047 is a Edetate Calcium Disodium Injecti, manufactured by Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-717-0047 has 1 manufacturer part number on file: NDC64980-0588-51 (Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals).
Key specifications for NDC64980-0588-51: Administration: INTRAMUSCULAR AND INTRAVENOUS; Primary Container Content Quantity: 5.0 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.